Researchers from the David Geffen School of Medicine at UCLA and UCLA Jonsson Comprehensive Cancer Center have received a $2.7 million grant from NCI to develop techniques to improve the quality of prostate magnetic resonance imaging and new artificial intelligence methods that use prostate MRI to assist cancer diagnosis.
The five-year project, led by Kyung Sung, associate professor of radiology, and Holden Wu, associate professor of radiology, bioengineering and biomedical physics, will help radiologists improve their ability to diagnose prostate cancer and help identify and predict the aggressiveness of the disease.
The new techniques will be evaluated in men who undergo prostate MRI and proceed to biopsy or surgery.
Previous studies led by Sung have shown artificial intelligence can perform as well as experienced radiologists in detecting prostate cancer. Improvements to the current system could help not only save time but potentially provide diagnostic guidance to less-experienced radiologists. Sung and Wu have also developed advanced quantitative MRI techniques that will be combined with artificial intelligence to maximize the performance for prostate cancer diagnosis.
A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement.